Methods of reducing risk of cardiovascular events in atrial fibrillation and/or atrial flutter subjects
In various embodiments, the present disclosure provides methods of reducing the risk of cardiovascular events in a subject receiving statin treatment and suffering from atrial fibrillation and/or flutter by administering to the subject a pharmaceutical composition comprising from about 1 g to about...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | Chinese English |
Published |
30.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | In various embodiments, the present disclosure provides methods of reducing the risk of cardiovascular events in a subject receiving statin treatment and suffering from atrial fibrillation and/or flutter by administering to the subject a pharmaceutical composition comprising from about 1 g to about 4 g of ethyl eicosapentaenoate or a derivative thereof.
在多个实施例中,本公开提供了通过向受试者施用包含约1g至约4g二十碳五烯酸乙酯或其衍生物的药物组合物来降低接受他汀类药物治疗并患有心房纤颤和/或扑动的受试者心血管事件风险的方法。 |
---|---|
Bibliography: | Application Number: CN202211705517 |